Long-term Follow-up on Childhood Adiposity - The FitKids Study
1 other identifier
observational
178
1 country
1
Brief Summary
The FitKids study is a mother-child observational cohort study on obesity and metabolism in children three years of age. The study will follow up on the FitMum and FitBaby studies, conducted from 2018-2022. The children in FitKids are born by mothers who completed the FitMum study, a single-site three-armed RCT, targeting physical activity during pregnancy. 220 pregnant women were randomly assigned to one of three arms during pregnancy: structured supervised exercise training, motivational counselling supported by health technology, or a control group receiving standard treatment. From inclusion and until one-year post-partum, the women wore an activity tracker 24/7 providing important information about adherence to the prescribed intervention. The primary objective of the FitKids study is to investigate the effect of lifestyle interventions during pregnancy on body composition (fat percentage measured by dual energy x-ray absorptiometry) and risk of childhood obesity in off-springs. The secondary objectives are to investigate the effect of lifestyle interventions during pregnancy on obesity-associated dys-metabolic traits and mental health in off-springs as well as to gain insight into presumed causal factors for overweight and obesity in children. The investigators hypothesize that children of mothers, who during their participation in FitMum, received an intervention will have a healthier body composition expressed as a fat percentage within the normal range for a 3-year-old child compared to children of mothers in the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 6, 2022
CompletedStudy Start
First participant enrolled
October 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedOctober 12, 2022
October 1, 2022
1.4 years
September 26, 2022
October 10, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
fat percentage
fat percentage in three-year-old children of mothers who gave birth while still participating in the FitMum study measured by dual energy x-ray absorptiometry and Air Displacement Plethysmography technology
Collection from October 2022 until June 2024
Secondary Outcomes (17)
BMI
Collection from October 2022 until June 2024
Waist-hip ratio
Collection from October 2022 until June 2024
Skinfolds
Collection from October 2022 until June 2024
Blood pressure
Collection from October 2022 until June 2024
Heart rate
Collection from October 2022 until June 2024
- +12 more secondary outcomes
Eligibility Criteria
The research team is still in contact with the participants in FitMum and all children of mothers who completed FitMum will be invited to participate in the FitKids study. The FitMum cohort is 'loyal' as 81% of participants have remained in the study at least until delivery. Therefore, 178 children will be eligible for inclusion and receive an invitation to participate in the FitKids study. A subgroup of the children (n = 147) participated in or are currently participating in the FitBaby study at one year of age.
You may qualify if:
- Written informed consent obtained from custody holders before any study related procedures are performed
- The participants must be born by mothers participating in FitMum and born during the intervention period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nordsjaellands Hospitallead
- Novo Nordisk A/Scollaborator
Study Sites (1)
Nordsjaellands Hospital
Hillerød, 2400, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grete K Teilmann
Nordsjaellands Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
September 26, 2022
First Posted
October 6, 2022
Study Start
October 10, 2022
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
October 12, 2022
Record last verified: 2022-10